Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

92
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
92
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

91
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
91
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

148
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

135
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
135
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

139
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
139
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

931
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
931

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting mortality with machine learning & biomarkers: A cohort analysis from aerosolized β₂-agonist for treatment of acute lung injury (ALTA) trial.

Physiological reports·2026
Same author

Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections.

Pharmacotherapy·2024
Same author

Evaluation of Critical Care Pharmacist Evening Services at an Academic Medical Center.

Hospital pharmacy·2024
Same author

Magnetic Properties of Amorphous Ta/CoFeB/MgO/Ta Thin Films on Deformable Substrates with Magnetic Field Angle and Tensile Strain.

Sensors (Basel, Switzerland)·2023
Same author

Stimulation of Angiotensin II Type 2 Receptor Modulates Pro-Inflammatory Response in Microglia and Macrophages: Therapeutic Implications for the Treatment of Stroke.

Life (Basel, Switzerland)·2023
Same author

Overview and Update on Methods for Cargo Loading into Extracellular Vesicles.

Processes (Basel, Switzerland)·2021

Related Experiment Video

Updated: Nov 18, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.4K

High-Dose Daptomycin and Clinical Applications.

Timothy W Jones1, Ah Hyun Jun2, Jessica L Michal3

  • 1University of Georgia College of Pharmacy, Augusta, GA, USA.

The Annals of Pharmacotherapy
|February 4, 2021
PubMed
Summary
This summary is machine-generated.

High-dose daptomycin (≥ 8 mg/kg/d) shows efficacy in serious gram-positive infections like endocarditis and bacteremia. Clinicians should consider higher daptomycin doses for improved patient outcomes.

Keywords:
daptomycingram positivehigh dosepharmacotherapy

More Related Videos

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.1K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.1K

Related Experiment Videos

Last Updated: Nov 18, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.4K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.1K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.1K

Area of Science:

  • Pharmacology and Infectious Diseases
  • Antimicrobial Stewardship

Background:

  • Daptomycin is a lipopeptide antibiotic effective against gram-positive bacteria.
  • Evidence for high-dose daptomycin (≥ 8 mg/kg/d) in complex infections is evolving.
  • Optimizing daptomycin dosing is crucial for managing challenging infections.

Purpose of the Study:

  • To evaluate the evidence supporting the use of high-dose daptomycin (≥ 8 mg/kg/d).
  • To analyze the efficacy and safety of high-dose daptomycin in serious gram-positive infections.
  • To inform clinical practice regarding daptomycin dosing standards.

Main Methods:

  • Comprehensive literature search of PubMed/MEDLINE (January 2000–December 2020).
  • Inclusion of clinical trials, observational studies, meta-analyses, and systematic reviews.
  • Review of references from review articles and society guidelines.

Main Results:

  • High-dose daptomycin demonstrates superior experimental activity against high inoculum and biofilm infections.
  • Clinically, high-dose daptomycin is supported for endocarditis and bacteremia, particularly MRSA and Enterococcus.
  • Efficacy is suggested for osteomyelitis and CNS infections, though comparative data are limited.
  • Special populations like burn patients and those on renal replacement therapy require adjusted dosing considerations.

Conclusions:

  • High-dose daptomycin exhibits favorable efficacy and a manageable safety profile in severe gram-positive infections.
  • Clinicians are encouraged to consider higher daptomycin doses more broadly for appropriate indications.
  • Further research is needed to clarify dosing in specific patient populations and complex scenarios.